Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism
Yaojie Fu(National Institutes of Health), Hong Shen(Central South University), Zhanwei Zhu(Central South University), Dechun Feng(National Institutes of Health), Bryan Mackowiak(National Institute on Alcohol Abuse and Alcoholism), Ying Han(Beijing University of Chemical Technology), Cao Guo(Central South University), Shan Zeng(Central South University), Shanshan Liu(Central South University), Bin Gao(National Institute on Alcohol Abuse and Alcoholism), Yong He(State Council of the People's Republic of China), Robim M. Rodrigues(Vrije Universiteit Brussel)
Cited by 32
Related Papers
Hepatocytes: a key cell type for innate immunity
|Cellular and Molecular Immunology|2015|449
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
|Hepatology|2012|438
Patient-derived xenograft models in cancer therapy: technologies and applications
|Signal Transduction and Targeted Therapy|2023|419
Alcohol-associated liver disease
|Journal of Clinical Investigation|2024|304